Pura Vida Investments β 2021 Investments
4 investments dated 2021 Β· listed companies and verified rows first Β· show all
Field Trip Health provides ketamine-assisted therapy for treatment-resistant depression and anxiety, offering rapid symptom relief through clinically monitored ketamine administration combined with psychotherapy.
Digital HealthHealthtechMedical DevicesMental Health
Co-investorsFrontera Technology VenturesEarl Grey CapitalJennison AssociatesSoleus CapitalSphera Funds Management
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level.
BiotechDeep TechHardwareMedical Devices
Andrea(Co-founder & Chief Scientific Officer)Gerrit(Co-founder & Director of Product Management and Marketing)Hugo(CEO)Edmee(Chief Financial Officer)Hannah(HR Director)
Co-investorsLauxera Capital PartnersSoftBank Vision FundEuropean Investment BankGilde HealthcareIrving InvestorsT. Rowe Price
Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Rob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in
Co-investorsARCH Venture PartnersNorthpond Ventures6 Dimensions CapitalAlly Bridge GroupApplied VenturesKilonova Capital+3 more
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.